Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$629M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$521M |
| 3 |
Apple
AAPL
|
+$389M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$274M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$756M |
| 2 |
PX
Praxair Inc
PX
|
+$742M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$584M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$546M |
| 5 |
State Street SPDR Dow Jones International Real Estate ETF
RWX
|
+$426M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.52% |
| 2 | Healthcare | 9.77% |
| 3 | Financials | 9.21% |
| 4 | Industrials | 8.27% |
| 5 | Consumer Discretionary | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4601
Natural Health Trends
NHTC
$14.8M
| $264K | ﹤0.01% |
14,267
+920
| +7% | +$20.2K |
|
|
DCP
4602
PUT
DELISTED
DCP Midstream, LP
DCP
| $264K | ﹤0.01% |
+30,700
| New | +$1.1M |
|
4603
Tejon Ranch
TRC
$451M
| $263K | ﹤0.01% |
15,864
-13,271
| -46% | -$247K |
|
|
EPZM
4604
DELISTED
Epizyme, Inc
EPZM
| $263K | ﹤0.01% |
42,693
+10,432
| +32% | +$79.7K |
|
4605
Mid Penn Bancorp
MPB
$952M
| $262K | ﹤0.01% |
11,392
+8,885
| +354% | +$228K |
|
|
GFN
4606
DELISTED
General Finance Corporation
GFN
| $262K | ﹤0.01% |
25,889
+16,958
| +190% | +$221K |
|
4607
First United
FUNC
$289M
| $261K | ﹤0.01% |
16,385
+2,098
| +15% | +$37.6K |
|
4608
Gold Fields
GFI
$36.5B
| $261K | ﹤0.01% |
74,285
+61,843
| +497% | +$182K |
|
4609
PUT
Norwegian Cruise Line
NCLH
$8.84B
| $261K | ﹤0.01% |
50,000
| – | – |
|
4610
Impinj
PI
$5.6B
| $261K | ﹤0.01% |
17,996
-732
| -4% | -$14.4K |
|
4611
RPC Inc
RES
$1.3B
| $261K | ﹤0.01% |
26,406
-133,281
| -83% | -$1.81M |
|
4612
iShares Convertible Bond ETF
ICVT
$7.35B
| $260K | ﹤0.01% |
+4,941
| New | +$274K |
|
|
TTP
4613
DELISTED
TORTOISE PIPELINE & ENERGY FUND, INC.
TTP
| $260K | ﹤0.01% |
5,248
-76
| -1% | -$4.56K |
|
4614
Forte Biosciences
FBRX
$1.57B
| $259K | ﹤0.01% |
84
+1
| +1% | +$4.31K |
|
4615
Lennar Class B
LEN.B
$20.8B
| $259K | ﹤0.01% |
8,711
-498
| -5% | -$16.4K |
|
4616
Q32 Bio
QTTB
$464M
| $258K | ﹤0.01% |
640
+297
| +87% | +$112K |
|
4617
KVH Industries
KVHI
$157M
| $257K | ﹤0.01% |
24,971
+1,393
| +6% | +$15.9K |
|
4618
MVB Financial
MVBF
$389M
| $257K | ﹤0.01% |
14,297
+3,508
| +33% | +$64K |
|
|
ARA
4619
DELISTED
American Renal Associates Holdings, Inc
ARA
| $257K | ﹤0.01% |
22,368
+3,740
| +20% | +$63.8K |
|
|
CASI
4620
DELISTED
CASI Pharmaceuticals
CASI
| $256K | ﹤0.01% |
6,368
+107
| +2% | +$4.05K |
|
4621
NI Holdings
NODK
$320M
| $256K | ﹤0.01% |
16,278
-971
| -6% | -$15.5K |
|
|
GDP
4622
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $256K | ﹤0.01% |
18,953
+17,572
| +1,272% | +$247K |
|
|
GPX
4623
DELISTED
GP Strategies Corp.
GPX
| $256K | ﹤0.01% |
20,250
+572
| +3% | +$8.17K |
|
4624
PUT
CVS Health
CVS
$122B
| $255K | ﹤0.01% |
90,000
-7,500
| -8% | -$560K |
|
4625
Foster
FSTR
$432M
| $255K | ﹤0.01% |
16,025
+1,360
| +9% | +$25.4K |
|
Similar funds
Wells Fargo's Q4 2018 Portfolio in Review
As of Q4 2018, Wells Fargo held 6,931 positions worth $301B, down 15% from $354B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Wells Fargo's Q4 2018 filing shows 326 new, 2,822 increased, 2,765 reduced and 349 closed positions. Its largest new stake was Linde: 3,977,010 shares worth $621M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $756M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q4 2018 buy was Linde: 3,977,010 shares worth $621M.
- Wells Fargo added most to iShares Core MSCI Emerging Markets ETF in Q4 2018, an estimated $521M increase.
- Wells Fargo's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $756M.
- Wells Fargo fully exited Praxair Inc in Q4 2018, selling an estimated $742M.
- Wells Fargo's ten largest holdings make up 14% of its $301B portfolio in Q4 2018.
- Wells Fargo opened 326 new positions and closed 349 in Q4 2018.
- Wells Fargo's portfolio value fell 15% quarter-over-quarter to $301B.
Based on Wells Fargo's 13F filing for Q4 2018, filed 11 Feb 2019.